The "Lazy Cancer" That Isn't: Fighting Thyroid Cancer's Deadliest Form
July 12, 2026
Most thyroid cancers are slow and highly treatable, but Anaplastic Thyroid Carcinoma (ATC) allows only months of survival. A multi-disciplinary team saved a case deemed inoperable.
Most thyroid cancers are slow-growing and highly treatable. But there's one exception: Anaplastic Thyroid Carcinoma (ATC), the "king of cancers" with a survival rate of mere months.
At Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, our multi-disciplinary team (MDT) recently won a race against time for a 65-year-old patient.
The challenge: The patient presented with a rapidly growing neck mass. Diagnosis: ATC, with tumor invasion into major veins — a condition often deemed inoperable.
Our integrated approach:
Precision diagnosis: Advanced ultrasound and CT identified the tumor and extensive cancer thrombus.
MDT strategy: Within 24 hours, specialists from Head & Neck Surgery, Cardiology, Thoracic Surgery, Medical Oncology, and Radiation Oncology convened. A key hurdle: the patient's severe heart block. Our cardiologists implanted a temporary pacemaker to enable safe anesthesia.
High-stakes surgery: Surgeons successfully removed the primary tumor and the entire cancer thrombus in one block, achieving a complete R0 resection — without opening the chest or requiring a blood transfusion.
The patient safely underwent surgery and is now receiving targeted immunotherapy, turning a terminal prognosis into a fighting chance.
Not all thyroid cancers are "lazy." Rapid neck swelling requires immediate expert care. This case showcases how integrated, high-level MDT care can push the boundaries of what's possible in oncology.
Related Images
